Prosecution Insights
Last updated: November 20, 2026
Application No. 19/081,048

FACILITY PRESENTATION APPARATUS, FACILITY PRESENTATION METHOD AND RECORDING MEDIUM

Final Rejection §101§DOUBLEPATENT
Filed
Mar 17, 2025
Priority
Apr 22, 2021 — nonprovisional of PCTJP2021016349 +2 more
Examiner
LI, SUN M
Art Unit
3685
Tech Center
3600 — Transportation & Electronic Commerce
Assignee
NEC Solution Innovators Ltd.
OA Round
2 (Final)
54%
Grant Probability
Moderate
3-4
OA Rounds
2y 4m
Est. Remaining
81%
With Interview

Examiner Intelligence

Grants 54% of resolved cases
54%
Career Allowance Rate
409 granted / 762 resolved
+1.7% vs TC avg
Strong +27% interview lift
Without
With
+27.1%
Interview Lift
resolved cases with interview
Typical timeline
4y 0m
Avg Prosecution
22 currently pending
Career history
792
Total Applications
across all art units

Statute-Specific Performance

§101
35.5%
-4.5% vs TC avg
§103
31.2%
-8.8% vs TC avg
§102
18.1%
-21.9% vs TC avg
§112
11.6%
-28.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 762 resolved cases

Office Action

§101 §DOUBLEPATENT
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . This communication is Final Office Action in response to amendment and remarks filed on 9/17/2026. Claims 1-20 have been examined and are pending. Response to Amendment The amendment filed on 9/17/2026 cancelled no claim. No claims were previously cancelled. No new claims are added. Claims 1, 8, 15 were amended. Therefore, claims 1-20 are pending and addressed below. The newly amended independent claim 1, 8, 15 obviates the statutory double patenting rejection, however, it raises a new ground of non-statutory double patenting rejection. Therefore, claims 1-20 are pending and addressed below. Claim Objections Claim 12 is objected to because of the following informalities: Claim 12 recites a presentation apparatus according to claim 8 which is a method claim. Appropriate correction/clarification is Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. Effective January 1, 1994, a registered attorney or agent of record may sign a terminal disclaimer. A terminal disclaimer signed by the assignee must fully comply with 37 CFR 3.73(b). Claims 1-20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-9 of allowed Application No. 18/007763 (reference application, now Patent 12,283,370). Although the claims at issue are not identical, they are directed to the same invention. For reference, the following table matches the primary limitations of pending claim 8 (method) of application 18/007763, with similar limitations of claim 8 (method) of the instant application (differences highlighted in bold type). 19/081048, instant application which is a continuation patent application 18/007763 18/007763, reference application, (now Patent 12,283,370), allowed claim 8. A facility presentation method performed by a computer and comprising: 8. A facility presentation method performed by a computer and comprising: receiving, through a user interface, a facility presentation request for a medical checkup target person; determining a recommended medical checkup in response to the facility presentation request; inputting information about the recommended medical checkup to a model learned by using machine learning to output recommended facility information including at least a name of the recommended facility; displaying, through the user interface, the recommended facility information including at least a name of the recommended facility; receiving, through the user interface, the user's designation of one recommended facility, wherein the model learned by using machine learning is trained by setting one of more parameters of the model so as to reduce an error between the recommended facility information output in response to input of learning data to the model and ground truth information, the learning data includes medical checkup information indicating a medical checkup that is related to healthcare and that is intended to be performed on the medical checkup target person, medical checkup facility information related to a plurality of medical checkup facilities at each of which the recommended medical checkup can be performed, and medical chart data of the medical checkup target person, and the ground truth information is information regarding a medical checkup facility to be selected as the recommended facility, and is generated in association with the learning data. determining a recommended medical checkup and a reservation-ready date and time when a facility presentation request is input from a user through a user interface; allowing a model learned by using machine learning to output recommended facility information for supporting decision-making of the user related to a recommended facility by inputting information about the recommended medical checkup, wherein the recommended facility information includes at least a name of the recommended facility; displaying a user interface including a display field indicating a name of the recommended facility the display field indicating the reservation-ready date and time for the recommended facility, the user interface operable by a medical checkup target person to obtain agreement of a medical checkup target person on use of medical chart data of the medical checkup target person by the recommended facility; notifying a designated facility that the medical checkup target person will take the recommended medical checkup when the user designates one recommended facility as the designated facility where the medical checkup target person will take the recommended medical checkup, through the user interface; and allowing at least one of transmission of the medical chart data to the designated facility through a communication network and access to the medical chart data using an API (Application Program Interface) by the designated facility, when the medical checkup target person agrees to the use of the medical chart data by the designated facility, wherein the model learned by using machine learning is set with at least one of a weight and a bias of a neural network so as to reduce an error between the recommended facility information output when learning data is input and ground truth information, the learning data includes medical checkup information indicating a medical checkup that is related to healthcare and that is intended to be performed on the medical checkup target person, medical checkup facility information related to a plurality of medical checkup facilities at each of which the recommended medical checkup can be performed, and the medical chart data, and the ground truth information is information regarding the medical checkup facility that is desired to be selected as the recommended facility, and is generated in association with the learning data. This is a nonstatutory double patenting rejection because the patentably indistinct claims have in fact been patented. Independent claim 1, 15 is similarly rejected. Therefore, as discussed above, the scope of claim 8 (method) of the present application and allowed claim 8, (method) respectively of U.S. Application No. 18/007763 (now Patent 12,283,370) are practically indistinguishable. Although the claims at issue are not identical, they are not patentably distinct from each other because the claims are directed to the same subject matter, perform the same method steps, and a person of ordinary skill in the art would not be free to practice one of the claimed inventions without infringing upon the other invention. It would have been obvious to the person having ordinary skill in the art before the effective filing date of the application to include “obtaining agreement”, “accessing data via API”, “using machine learning is set with at least one of a weight and a bias of a neural network”, claimed in this application as taught or suggested by claims 1, 8, 9 of patent application 18/007763 because instant application claims 1-20 would have been obvious over the reference claims 1-9 in allowed application 18/007763. An approved Terminal Disclaimer is required. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/process/file/efs/guidance/eTD-info-I.jsp. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-20 are NOT rejected under the Alice/Mayo styled 35 U.S.C. 101 because the claimed invention integrates the abstract idea into a practical application. Applicant’s instant claims are deemed to be persuasive as the combination of elements, the claim as a whole, recite the specifics of performing training using the training data to construct a learning model that outputs a selection of a medical checkup facility recommended to a medical checkup target person who wants to take a medical checkup derived from the learning model and is also known as an output of a neural network after an input image is subject to a certain filtering, to overcome Alice 101 rejection. As such, the claim qualifies as eligible subject matter under 35 U.S.C. 101. After reviewing the Applicant’s disclosure as well as the amended claimed limitations that are included in the pending claim language, it is clear to the Examiner that the steps being performed go beyond the limitations and simple implementation of an abstract idea. The claimed invention integrates the judicial exception into a practical application. This statement is simply made to inform the record that the claims were considered under the Alice/Mayo analysis. Allowable Subject Matter As to the prior art rejections, in interpreting the claims, considering the specification, upon further search and consideration, and for the reasons presented by the claims, the Examiner finds the claimed invention to be patentably distinct from the prior art of records. It is found that claim 1-20 is allowable subject to outstanding Double Patenting rejections. Independent claims 1, 8, 15 as a whole recite a combination of limitations that has Not been found as define over prior art of record (the combination of Colsser (US 2022/0383998), Hiral et al. (US 2021/0391077), Tapia (US Patent 10708795), Kapoor et al. (US 2015/0133784), were directed towards the entirety of the claimed subject matter and was the best reference known to one of ordinary skill in the art to address the instant claims as well as the additional references of Bostic et al (US 2021/0005324), Nagashima et al. (US 2019/0189280), Abousy et al. (US 2019/0392931), Okumura et al. (US 2013/0204635), Ramasubramanian et al. (US 2008/0201174), and the other references teach all the claimed features. None of the prior art teaches or suggests specifying the type of selection of one medical checkup facility that is recommended to a medical checkup target person from a plurality of medical checkup facilities based on a medical checkup information indicating a medical checkup that is related to a healthcare and that is intended to be taken by the medical checkup target person, as variously claimed. However, independent claims 1, 8, 15 and their dependency are rejected under Double Patenting above. As allowable subject matter has been indicated, applicant's reply must either comply with all formal requirements or specifically traverse each requirement not complied with, and pending remedy to outstanding issues cited above. See 37 CFR 1.111(b) and MPEP § 707.07(a). The prior art made of record and Not relied upon is considered pertinent to applicant’s disclosure. Kirenko et al. (US 2021/0176357, teaches determining a priority level and/or conversation duration of a call. In particular, determine the health condition of the user who is initiating a call, based on extracted physiological data and use the information on the health condition of the user to determine the priority level and/or conversation duration of the call). Chen et al. (US 2019/0108914, teaches a health information analysis system configured to analyze, examine, search, investigate, consider, evaluate, and/or otherwise process health information and to generate various medical assessments based on the health information). Conclusion THIS ACTION IS MADE FINAL. Applicants are reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to SUN M LI whose telephone number is (571)270-5489. Fax is 571-270-6489. The examiner can normally be reached on Mon-Thurs, 8:30am--5pm Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kambiz Abdi, can be reached on 571-270-6702. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SUN M LI/ Primary Examiner, Art Unit 3685
Read full office action

Prosecution Timeline

Mar 17, 2025
Application Filed
Jun 17, 2026
Non-Final Rejection mailed — §101, §DOUBLEPATENT
Sep 17, 2026
Response Filed
Nov 10, 2026
Final Rejection mailed — §101, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12802110
SYSTEMS AND METHODS FOR GENERATING PERSONALIZED ITEM DESCRIPTIONS
2y 0m to grant Granted Nov 17, 2026
Patent 12802096
INDUSTRY GIFT VOUCHER WITH FENCE NETWORK: SYSTEM AND METHOD
1y 4m to grant Granted Nov 17, 2026
Patent 12784904
SYSTEMS AND METHODS FOR LOCALIZED MONITORING OF PATIENTS
2y 1m to grant Granted Nov 03, 2026
Patent 12776389
GRAPH REFERENCE GENOME AND BASE-CALLING APPROACH USING IMPUTED HAPLOTYPES
4y 2m to grant Granted Oct 27, 2026
Patent 12763167
METHODS, CIRCUITS, SYSTEMS, AND ARTICLES OF MANUFACTURE FOR SEARCHING A REFERENCE SEQUENCE FOR A TARGET SEQUENCE WITHIN A SPECIFIED DISTANCE
4y 3m to grant Granted Oct 13, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
54%
Grant Probability
81%
With Interview (+27.1%)
4y 0m (~2y 4m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 762 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month